Insider Transactions in Q4 2025 at Supernus Pharmaceuticals, Inc. (SUPN)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 09
2025
|
Charles W Newhall Iii Director |
SELL
Open market or private sale
|
Direct |
25,000
-9.75%
|
$1,275,000
$51.14 P/Share
|
|
Oct 09
2025
|
Jack A. Khattar President, CEO |
SELL
Open market or private sale
|
Direct |
59,900
-2.37%
|
$3,054,900
$51.0 P/Share
|
|
Oct 09
2025
|
Jack A. Khattar President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
81,250
+6.03%
|
$2,031,250
$25.3 P/Share
|
|
Oct 02
2025
|
Jack A. Khattar President, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,325
-0.65%
|
$704,950
$46.21 P/Share
|
|
Oct 02
2025
|
Jack A. Khattar President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
41,587
+1.15%
|
$332,696
$8.43 P/Share
|
|
Oct 02
2025
|
Jack A. Khattar President, CEO |
SELL
Open market or private sale
|
Direct |
1,904
-0.16%
|
$91,392
$48.06 P/Share
|
|
Oct 01
2025
|
Jack A. Khattar President, CEO |
SELL
Open market or private sale
|
Direct |
40,173
-3.34%
|
$1,928,304
$48.07 P/Share
|
|
Oct 01
2025
|
Jack A. Khattar President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
53,785
+4.29%
|
$1,344,625
$25.3 P/Share
|